IMAC HOLDINGS INC (IMAC) Stock Fundamental Analysis

USA • Nasdaq • NASDAQ:IMAC • US44967K1043

1.01 USD

+0.02 (+2%)

Last: Aug 5, 2022, 08:25 PM

Fundamental Rating

Taking everything into account, IMAC scores 2 out of 10 in our fundamental rating. IMAC was compared to 102 industry peers in the Health Care Providers & Services industry. Both the profitability and financial health of IMAC have multiple concerns. IMAC is valied quite expensively at the moment, while it does show a decent growth rate.

Quickly go to:

1. Profitability

1.1 Basic Checks

IMAC had negative earnings in the past year.

1.2 Ratios

		Industry Rank	Sector Rank
ROA	-48.41%
ROE	N/A
ROIC	-45.82%

ROA(3y)N/A

ROA(5y)N/A

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

		Industry Rank	Sector Rank
OM	-72.27%
PM (TTM)	-76.98%
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so IMAC is destroying value.
Compared to 1 year ago, IMAC has more shares outstanding
Compared to 1 year ago, IMAC has an improved debt to assets ratio.

2.2 Solvency

Based on the Altman-Z score of -0.90, we must say that IMAC is in the distress zone and has some risk of bankruptcy.
IMAC has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.

		Industry Rank	Sector Rank
Debt/Equity	0.01
Debt/FCF	N/A
Altman-Z	-0.9

ROIC/WACC-5.63

WACC8.14%

2.3 Liquidity

IMAC has a Current Ratio of 1.27. This is a normal value and indicates that IMAC is financially healthy and should not expect problems in meeting its short term obligations.
IMAC has a Quick Ratio of 1.27. This is a normal value and indicates that IMAC is financially healthy and should not expect problems in meeting its short term obligations.

		Industry Rank	Sector Rank
Current Ratio	1.27
Quick Ratio	1.27

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

IMAC shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 13.64%, which is quite good.
The Revenue has grown by 21.05% in the past year. This is a very strong growth!
IMAC shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 272.72% yearly.

EPS 1Y (TTM)13.64%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%20%

Revenue 1Y (TTM)21.05%

Revenue growth 3Y29.01%

Revenue growth 5Y272.72%

Sales Q2Q%27.29%

3.2 Future

IMAC is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 2.32% yearly.
IMAC is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 22.61% yearly.

EPS Next Y2.98%

EPS Next 2Y7.43%

EPS Next 3Y4.29%

EPS Next 5Y2.32%

Revenue Next Year21.45%

Revenue Next 2Y23.21%

Revenue Next 3Y22.4%

Revenue Next 5Y22.61%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

IMAC reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year IMAC is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.